Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$1.06 - $1.67 $291,862 - $459,821
275,342 Added 24.74%
1,388,462 $1.61 Million
Q2 2023

Aug 11, 2023

BUY
$1.14 - $1.95 $227,999 - $390,000
200,000 Added 21.9%
1,113,120 $2.07 Million
Q1 2023

May 11, 2023

BUY
$1.2 - $2.19 $284,253 - $518,762
236,878 Added 35.03%
913,120 $1.21 Million
Q3 2022

Nov 08, 2022

BUY
$0.73 - $3.74 $493,656 - $2.53 Million
676,242 New
676,242 $2.11 Million

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $12.1B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.